Introduction
A photonics component vendor who has completed a successful technical evaluation — good data, validated performance, enthusiastic R&D feedback — and still lost the deal is not failing at the technical stage. They are failing at the commercial stage.
This distinction matters because the photonics industry invests heavily in technical excellence and comparatively little in commercial process. The assumption, often implicit, is that a technically superior product will win. In practice, the buying decision in an OEM evaluation involves multiple stakeholders with different objectives, a procurement process that introduces its own logic, and a risk framework that is often invisible to the supplier until it becomes decisive.
The framework presented here is not theoretical. It reflects patterns observed across more than fifteen years of OEM sales in photonics and precision optics markets — patterns consistent enough to be systematic, and specific enough to be actionable.
Why photonics OEM evaluations are different
Most B2B sales methodologies were designed for cycles measured in weeks or months. A photonics OEM evaluation typically runs from eighteen months to three years, involves a buying committee of six to twelve people with different functions and different risk tolerances, and results in a component specification that will stay in production for seven to ten years.
These characteristics create a set of commercial dynamics that generic sales training does not address:
- The technical evaluator and the commercial decision-maker are rarely the same person, and their criteria are often in tension.
- The switching cost of changing a component after design-in is extremely high — which means the buyer is making a strategic supplier relationship decision, not just a product selection.
- The procurement process in a regulated or precision-manufacturing context adds a qualification burden that can take longer than the technical evaluation itself.
- The "invisible veto holder" — the person who can block a decision that everyone else supports — is a recurring feature of large OEM buying committees and is almost never visible to the supplier until late in the process.
The three-phase evaluation framework
The following framework organises the buyer's actual evaluation logic into three phases, each with specific questions that a commercially prepared supplier should be able to answer. These are not the supplier's questions — they are the buyer's questions, surfaced through observation of how decisions are actually made.
Phase 1: Before the pilot — strategic fit and supplier profile
Before a formal evaluation begins, the buyer is assessing whether engaging with this supplier is worth the organisational investment. This phase is often invisible to the supplier, but it is where many evaluations are effectively decided. The questions the buyer is working through:
- Is this component technically necessary for what we are building, or is it a nice-to-have? Can we solve this problem with something we already qualify?
- Is this supplier commercially viable as a long-term partner — financially stable, with a credible supply chain for the production volumes we will eventually need?
- Does this supplier understand our application? Have they worked in our vertical before, and do they have reference customers in comparable use cases?
- What is the integration burden? How much engineering resource will we need to commit to the evaluation, and is the supplier's application support capable of reducing that burden?
- What is our fallback if this relationship does not work out? Is there an alternative supplier we could qualify if needed?
The implication for suppliers: the first conversations in a photonics OEM evaluation are not product conversations. They are supplier credibility conversations. A supplier who leads with technical specifications before establishing their commercial profile and application expertise is answering questions the buyer has not yet asked.
The most common mistake at Phase 1 is treating the first technical contact — typically an R&D engineer or applications scientist — as the evaluator. They are the technical evaluator, but they are rarely the decision-maker. The question "who else will be involved in this decision?" should be asked explicitly in the first substantive meeting.
Phase 2: During the evaluation — technical and commercial parallel tracks
The formal evaluation phase involves two tracks running simultaneously. The supplier typically sees the technical track. The commercial track — running inside the buyer's organisation — is often entirely invisible to the supplier and is where most deals stall or fail.
On the technical track, the buyer is assessing:
- Does the component meet the performance specification under real operating conditions — not just in the vendor's application note?
- What is the integration complexity? How much re-engineering of our system does this component require, and what risks does that introduce?
- What is the reliability data? MTBF, environmental testing, lifetime under our specific duty cycle — not generic datasheet figures?
On the commercial track, the buyer is simultaneously working through:
- Has this supplier been formally assessed by our procurement team? Are they on our approved vendor list, or what is the qualification path?
- What are the commercial terms — lead times, MOQ, pricing at production volumes, warranty, liability — and are they within our procurement framework?
- What is the risk to our programme if this supplier has a supply chain disruption?
The critical insight: the commercial track has its own decision-makers who typically enter the evaluation later than the technical evaluators but whose concerns are no less significant. A supplier who has managed only the technical relationship will encounter these stakeholders at the commercial stage without any established relationship or credibility.
The best indicator that a deal is progressing commercially — not just technically — is when the buyer's champion introduces you to someone outside R&D without you having asked for the introduction. A champion who has not done this by the time the pilot results are positive is a champion who has not yet started the internal commercial process.
Phase 3: Before commercial negotiation — risk and decision process
The final phase before a purchase order is issued is when the Risk Owner — the person inside the buyer's organisation who bears the consequence if the supplier relationship fails — makes their assessment. Their concerns are different in character from both the technical evaluator's and the procurement team's:
- What happens to our product and our production schedule if this supplier cannot deliver? What is our contingency?
- Who in our organisation is accountable for this decision, and are they confident in the risk profile?
- What is the internal business case for selecting this supplier rather than an alternative — and is our champion capable of making that case to the people whose approval we need?
This last question is the one that most suppliers never address directly. The internal business case — the argument the buyer's champion needs to make to their colleagues and to the final approver — is almost never a technical argument. It is a risk argument, and it needs to be constructed with the supplier's help.
The cost of commercial inaction
To make the stakes concrete: consider a component at €2,500 unit price, 800 units per year, eight-year design-in lifetime. Annual contract value: €2M. Lifetime value: €16M.
The win-rate difference between a commercially prepared supplier and a technically-only supplier in this market is approximately 30 percentage points. The expected value of commercial preparation on a single deal: €4.8M.
Three dynamics make this figure conservative. First, the design-in lock-in effect: a won deal generates revenue for the full production lifetime of the buyer's product — in photonics, often fifteen to twenty years. Second, the compounding reference effect: a competitor who wins the design-in acquires a reference customer in your target application, cited in every subsequent evaluation in that vertical. Third, the opportunity cost of stalled evaluations: a senior application engineer committed to a twelve-month pilot that is not progressing commercially is not available for early-stage development work with higher-probability opportunities.
Commercial implications for photonics vendors
The framework above has several direct implications for how photonics component suppliers approach OEM evaluations.
First, stakeholder mapping should begin at the first meeting, not at the commercial stage. Identifying the Technical Authority, the Commercial Gatekeeper, the Risk Owner, and the Champion — and understanding their individual concerns — is not a one-time exercise. It is an ongoing process that shapes every interaction in the evaluation.
Second, the application engineering relationship has commercial value that is systematically under-leveraged. The supplier who is fastest to respond to integration challenges, most proactive in sharing relevant data, and most technically credible in the buyer's application context is building a commercial advantage that competitors cannot easily displace.
Third, supporting the internal business case is a commercial activity, not a marketing one. This means understanding what the Risk Owner's specific concern is, providing the right data and framing at the right time — not producing a generic presentation that the champion may not be able to use effectively in an internal conversation.
Conclusion
Photonics OEM markets reward technical excellence — but they do not award purchase orders on that basis alone. The vendors who consistently win evaluations in this market are those who understand the full buying process: who is involved, what each person is managing, and what the buyer needs at each stage to advance the decision internally.
The 14 questions in this framework are a diagnostic tool. A supplier who can answer all of them — with specific, evidence-based answers — for an active evaluation is commercially prepared. A supplier who cannot answer several of them has identified where the risk in their pipeline actually lies.
In a market where a single OEM design-in can generate eight-figure revenue over its lifetime, the investment required to build commercial competence alongside technical excellence is not a cost — it is the highest-return activity available to a photonics component vendor.
FAQ: OEM buyer evaluation in photonics
What is the most common reason a photonics vendor loses a deal after a successful technical evaluation?
Failure to manage the commercial track — the procurement qualification, Risk Owner concerns, and internal business case construction that runs in parallel with the technical evaluation but is largely invisible to the supplier. The pilot produces a positive result. The commercial track, unmanaged, produces a "we've decided to go in a different direction" with no explanation.
Who is the "invisible veto holder" in a photonics OEM evaluation?
A person who can block a decision that everyone else has approved — typically a VP of Operations, a CTO, or a divisional GM who was not part of the evaluation but whose approval is required for the final purchase decision. Their concern is almost never technical. It is supply chain risk, programme continuity, and organisational accountability. The question to ask your champion early: "Who in your organisation would be most concerned if this decision went wrong?" That person needs to be addressed — through the champion — before the approval stage.
How should a photonics vendor develop a champion inside a buying organisation?
A functioning champion does five things: introduces you to other stakeholders without being asked, shares internal information the supplier could not access otherwise, makes the internal business case in meetings the supplier does not attend, gives early warning when something changes, and has a professional stake in the outcome. Most people called champions are doing one or two of these. The supplier's job is to equip the champion — with the right data, the right framing, and the right preparation for the objections they will face — not just to rely on their enthusiasm.